UCLA researchers discover new disorder that causes chronic diarrhea in childrenJuly 20, 2006Discovery may help further stem cell research for type I diabetes and intestinal disorders UCLA researchers have unraveled a mysterious condition that causes congenital diarrhea and intestinal failure in children. The new disorder, named enteric anendocrinosis, is caused by a mutation in the gene Neurogenin-3 (NEUROG3). The findings represent the first description of a disease-causing mutation of NEUROG3 in humans and the first new discovery within the past 15 years of a disorder that causes intestinal failure. Patients with this condition have an abnormally low number of endocrine cells in their intestine and also eventually develop type I diabetes. "Rare diseases help us understand how the body works," said principal investigator, Dr. Martín G. Martín, professor of pediatrics in the division of gastroenterology and nutrition at Mattel Children's Hospital at UCLA. "We now know that the hormone-producing endocrine cells of the intestine have an essential role in facilitating nutrient absorption. These findings have already led to the detection of subset forms of enteric anendocrinosis." Martín and his colleagues describe their research in the July 20 issue of the peer-reviewed New England Journal of Medicine. The study focuses on three children who each showed symptoms of vomiting, diarrhea and dehydration during the first few weeks of life, following consumption of formula. Researchers used genomic DNA from the patients to screen for mutations of NEUROG3. They then tested the ability of the mutations to alter NEUROG3's function. Martín anticipates that this discovery will provide the framework to further understand type I diabetes, as well as other diarrheal disorders, including inflammatory bowel disease and diarrhea-predominant irritable bowel syndrome. "Since patients with enteric anendocrinosis develop type I diabetes, we hope stem cell researchers can apply the knowledge from this discovery to the role of NEUROG3 in the development of insulin-producing islet cells in the pancreas," Martín said. "In mice, Neurogenin-3 initiates the development of the endocrine cells in the pancreas, including the insulin-producing cells," said Dr. Michael German, professor of medicine at the University of California, San Francisco, Hormone Research Institute. "In the absence of Neurogenin-3, no insulin-producing cells are generated in the pancreas, and the animals develop diabetes at birth. Therefore, Neurogenin-3 has been termed a 'pro-endocrine' gene, since it drives progenitor cells to mature into endocrine cells." "The cure for enteric anendocrinosis and diabetes-two diseases that involve failure of a specific type of cell-may eventually be derived from stem cells that are able to replace the dysfunctional cells and produce the right kind of hormones," said Dr. Doron Kahana, a pediatric gastroenterology research fellow in Martín's lab. There are about 30 known causes of chronic diarrhea. It affects approximately 5 percent of the population and only rarely occurs during the first several weeks of life. Unlike acute diarrhea-which is normally caused by a virus, bacteria or parasite and generally improves within a few days or weeks-chronic diarrhea persists and can lead to severe malnutrition and growth failure in children. For newborns with enteric anendocrinosis, their condition is worsened by eating. Treatment usually involves specialized formulas and intravenous nutrition to minimize the diarrheal symptoms and promote growth. Currently, there is no cure for the illness. University of California-Los Angeles |
|||||||||||||||||||||
| Related Chronic Diarrhea Current Events and Chronic Diarrhea News Articles Gene discovered for newly recognized disease in Amish children The gene for a newly recognized disease has been identified thanks to the determination of an Amish father and the clinical skills and persistence of Indiana University and Riley Hospital for Children physicians in collaboration with physicians and researchers at the Clinic for Special Children in Lancaster County, Penn., which specializes in disorders of the Amish. Chronic diarrhea unresponsive to conventional medication: Are you taking lansoprazole? Lansoprazole is a proton pump inhibitor which powerfully suppresses gastric acid production and is widely prescribed for chronic use in gastroesophageal reflux disease. A rare case of collagenous colitis presenting as protein-losing enteropathy Since the first report in 1976, collagenous colitis has been associated with a variety of conditions, including use of non-steroidal anti-inflammatory drugs and proton pump inhibitors. An epidemiologic study of microscopic colitis in Turkey The research team led by Levent Erdem from Şişli Etfal Teaching and Research Hospital of Turkey investigated the prevalence and demography of microscopic colitis in patients with diarrhea of unknown etiology and normal colonoscopy in Turkey. This will be published on 21 July 2008, in the World Journal of Gastroenterology addresses this question. UCLA researchers clarify function of glucose transport molecule Researchers at the David Geffen School of Medicine at UCLA have solved the structure of a class of proteins known as sodium glucose co-transporters (SGLTs), which pump glucose into cells. Mouse study: Real-time imaging device may improve surgery for congenital colon disease Researchers at Cedars-Sinai Medical Center are developing a spectral imaging system that could result in shorter operating times for infants undergoing surgery for Hirschsprung's disease, according to a mouse study reported in the Journal of Biophotonics. More Chronic Diarrhea Current Events and Chronic Diarrhea News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||